Ngaba ufumene i-a iqhuma endlebeni? Ukuba usandul' ukugqojozwa, inokuba sisiva se-hypertrophic, kodwa ukuba akunjalo, inokuba yi-keloid. Ukwenzakala eluswini okubangela ukukhula kwezicubu ezirhabaxa kwaye oko kunokubaxwa kakhulu.
I-keloid ingaba nayo imvelaphi eyahlukileyo kakhulu kwaye yanwenwe yada yaba buburhalarhume. Ucinga ukuba yi-keloid endlebeni? Khangela isiqinisekiso ngokubonisana netyala kunye nogqirha wakho wosapho kuqala kunye nedermatologist kamva.
Yintoni i-keloid?
IiKeloids zibangelwa yi-a ukukhula ngokugqithiseleyo kwezicubu ezibomvu. Zivela xa umatshini wokulungisa ulusu uvuliwe emva kokwenziwa kotyando, inxeba elibuhlungu, ukutshisa, umkrwelo omncinci okanye i-acne. Isiphumo sisiva esingaphaya kwemida yesilonda esibangele. Okwenzekayo ngokugqojozwa kubizwa ngokuba sisiva sehypertrophic.
Umfanekiso we Elisaveta Bunduche en Unsplash
Musa ukuyibhidanisa nesiva se-hypertrophic
Uthini umahluko phakathi kwesiva se-hypertrophic kunye ne-keloid? Ukukwazi kwayo ukusasazeka. Izivubeko zeHypertrophic, eziphakanyiswa ngokubanzi kwaye zilukhuni, zanda ngobunzima ngaphandle kokugqithisa imida yesilonda sokuqala. Kwindaba ye ukugqobhoza, ezi zibazi zivela emngxunyeni kwaye aziqhubeki. I-Keloids, nangona kunjalo, yanda phezu komhlaba kwaye inokubangela iingxaki ezininzi, kubandakanywa nobuhle.
Indlela yokuthintela
IiKeloids zinokuthintelwa ukuphepha ukwenzakala kunye nokucaphuka esikhumbeni esifana nezo zibangelwa kukugqojozwa, itattoos okanye ukuphatha iipustules, kodwa siyazi ukuba oku akusoloko kulula. Ukongezelela, emva kokuhlinzwa okanye ukubhoboza indlebe, kusoloko kubaluleke kakhulu ukuba silandele izikhokelo ezibekwe yingcali ukuze siphile ngaphandle kweengxaki.
ukubaphatha njani
Kwimeko ye-keloids ezindlebeni, kubalulekile ukuya kwi- ukubonisana nodermatologist kuvavanyo lwayo. Kungelo xesha kuphela apho ingcaphephe inokukhetha olona nyango lulungileyo olunokususela ekusetyenzisweni nje kwamafutha e-corticosteroid ukuya ekususweni kwawo ngotyando.
- Ijeli ye-silicone okanye i-patch. Ukusetyenziswa kweemveliso ze-silicone ezenza uxinzelelo oluthile kwisiva kuye kwaba yinto eqhelekileyo yonyango lokuqala ngenxa yokulula kunye nokusebenza kwayo. Kwaye kukuba iqikelela ukusebenza kwayo kwi-70-80% ukuphepha ukuphindaphinda kwe-hypertrophic scars kunye ne-keloids.
- Inaliti yeCorticosteroid. I-injection ye-corticosteroids kwi-keloid yindlela yokuqala yonyango lwe-keloids kwindlebe xa ingekho enkulu kakhulu. Akugcini nje ukuvumela izicelo ezininzi, kodwa unyango lunokuncediswa kunye nokusetyenziswa kwamafutha kunye ne-corticosteroids ephucula i-keloids ngeendlela ezahlukeneyo zokulwa nokuvuvukala. Ubulula bolawulo kunye nesantya sesenzo, kunye neempendulo ezithandekayo kwi-50-100% yamatyala, bathetha ngokwabo.
- ukususwa ngotyando. Ukususwa ngotyando kwee-keloids kwenziwa ngokudityaniswa nolunye unyango. Oku kunjalo ngenxa yomngcipheko omkhulu wokuphindaphinda kwee-keloids emva kokususwa. Okokuqala, ubukhulu be-keloid buncitshiswa ngotyando ukuze kamva olunye unyango, olufana nonyango lwe-radiation okanye inaliti ye-corticosteroid, lube nefuthe elikhulu.
- Unyango ngeRadio. Unyango lwemitha luhlala lwenziwa xa luboniswa kwiiyure ezingama-24 emva kokuba i-keloid isuswe ngotyando. Nangona kunjalo, ayifanelekanga kubantwana abangaphantsi kweminyaka eyi-18 kwaye ayikhuthazwa kwi-ear keloids ngenxa yomngcipheko wokuphuhliswa kwethumba elihambelana nokusetyenziswa kwemitha.
- unyango laser. Ukusetyenziswa kwe-laser kuboniswa kuphela kwezinye iimeko. Ngolu unyango kunokwenzeka ukulimaza iinqanawa ezondla i-keloid kunye nokunciphisa ukuveliswa kwe-collagen kunye nezinto ezikhuthaza umsebenzi we-fibroblasts.
- Iziyobisi ze-Immunosuppressive kunye ne-antitumor. Ezi ntlobo zamachiza ziye zafundwa kwaye zisetyenziselwa unyango lwe-ear keloids ngenxa yemiphumo yabo yokuthintela kwimisebenzi ye-fibroblast kunye ne-collagen synthesis.
Ezi zezinye zezona zidumileyo kunye / okanye unyango olusebenzayo lokunyanga i-keloid. Ingcali iya kukwazi ukukucebisa ukuba yeyiphi inketho efanelekileyo okanye ukudibanisa ukunyanga i-keloid endlebeni.